#Space pioneer momentus stock software
#Space pioneer momentus stock plus

All of these investments are subject to the same financial discipline that allows us to deliver meaningful profitability while also growing the top line at 20% or higher. Our investments in personal safety devices fall alongside our other growth investments, including software. We anticipate that consumer will be a growing area of investment for us over the long term given our incredibly low penetration of this sizeable market. The Bolt 2 is designed to immobilize attackers for up to 30 seconds. It will feature a 15-foot range, discreet design, enhanced features for improved accuracy in low-light, and the ability to alert emergency dispatch when discharged when paired with a companion app. Axon introduced plans for the Bolt 2, a new consumer device. The TASER Bolt 2 is Axon’s upcoming self-defense product. Both sides can have hours of video evidence to review for each case.

Often, public defenders have as little as six minutes with a client before entering a plea deal, while prosecutors have less than an hour to make a charging decision. The proliferation of digital evidence has forced highly-trained attorneys to spend up to a third of their time on clerical work. Axon’s R&D on the category began more than a year ago, and included hundreds of interviews with prosecutors and defense attorneys. Attorney Premier enables prosecutors and defense attorneys to easily manage various forms of digital evidence, including body-worn and in-car video, drone footage, interview room video, CCTV video, photographs, audio, documents and more.

#Space pioneer momentus stock software

It’s a bar that we continuously beat.Īxon launched Attorney Premier in December, formally entering the justice software market, which we estimate to be worth $1bn. This metric is typically used to evaluate pure SaaS companies, and has set a high bar for our entire business, which includes hardware.

#Space pioneer momentus stock plus

The way Axon invests in future growth while also demonstrating leverage is to target the Rule of 40 - where the sum of our top line growth percentage plus our Adjusted EBITDA margin percentage equals or surpasses 40. We are scaling new products and markets, and attracting and developing talent to continue executing on our mission. Our priority in 2022 is to *further excel at what we do* and we are focused on setting our teams up for success.

Our long-term model and financial targets remain unchanged: We aim to deliver a 20%+ top line CAGR, while building recurring revenue streams that support underlying Adjusted EBITDA margins of 30%, allowing us to reinvest for growth, as a Rule of 40 grower(1). The stories that we hear from customers and citizens about lives saved and communities feeling supported embolden us to continue innovating, to pursue new markets and expand Axon’s footprint into new geographies, executing against the $52bn total addressable market opportunity we laid out in November 2021.

This is especially true at a time when pandemics and social unrest have created far-reaching impacts personally, professionally and societally, around the world. This level of sustainable high growth and profitability underscores the importance and relevance of our mission to protect life. Our focus on building best-in-class subscription software, with a positive user experience, has driven our annual recurring revenue to $327m, tripling over three years.Īnd record annual bookings of $1.7bn, up 54% over 2020, point to strong growth ahead. Indeed, we have achieved a three year Adjusted EBITDA CAGR of 43%. While our net loss of $60m includes the impact of non-cash stock based compensation expenses, annual Adjusted EBITDA of $178m exceeded our guidance, reflected a 20.6% margin and showcases our ability to deliver profitability while investing heavily to scale. Over the past three years, we have delivered a 27% compound annual revenue growth rate. In 2021, we achieved revenue growth of 27% to $863m.

Building for racial equity, diversity, and inclusion.

Our 2021 results reflect strong operational and financial execution across the business.We are executing upon our vision to build the world’s largest and most trusted network of safety devices, in service of protecting life by: Not only is our goal to save attorneys time, but also to shorten the time people are jailed awaiting trial. Specifically, we are developing software to help prosecutors and defense attorneys streamline the discovery process. Axon Reports 2021 Results: Third Straight Year of 25%+ Revenue Growth.Īnnual bookings top $1.7bn, up 54% Annual recurring revenue of $327m, up 48%.Īxon’s expansion into justice software is a natural evolution of our market-leading cloud-hosted digital evidence management software category.